SCHEMBL19558478

SCHEMBL19558478

CC(C)C(=O)Nc1cc(C2OC2Nc2cnccc2C(F)c2ccccc2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 12/20 0.47
▸ GSK3B P49841 12/20 0.47
▸ GAA P10253 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ MAP4K1 Q92918 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19558459 0.82 MAPT (0.50) MAPTGSK3BNPC1RAB9ASMN1; SMN2
SCHEMBL19558476 0.82 GSK3B (0.46) MAPTGSK3BNPC1RAB9ASMN1; SMN2
SCHEMBL19558488 0.81 MAPT (0.47) MAPTGSK3BNPC1RAB9ASMN1; SMN2
SCHEMBL16703056 0.80 GSK3B (0.69) MAPTGSK3B
SCHEMBL16704195 0.68 KDM4C (0.47) MAPTGSK3BGAATHRBNPC1
SCHEMBL27342084 0.64 TYK2 (0.51) MAPTGSK3BNPC1RAB9ASMN1; SMN2
SCHEMBL16704164 0.64 GSK3B (1.00) MAPTGSK3B
SCHEMBL16710667 0.64 GSK3B (0.70) MAPTGSK3BKDM4C
SCHEMBL19699514 0.64 BRAF (0.61) MAPTGSK3BNPC1RAB9ASMN1; SMN2
SCHEMBL16711027 0.63 KDM4C (0.43) RAB9AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809573-B2 Substituted pyridine derivatives useful as GSK-3 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-11-07 — — US disclosed
Send feedback